Evidence map›Paper›PMID 31562329›Full record

ArticleNature communications2019

CXCR5

Yuhong Chen, Mei Yu, Yongwei Zheng, Guoping Fu, Gang Xin, Wen Zhu, Lan Luo, Robert Burns, Quan-Zhen Li, Alexander L Dent and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 89 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Tissue-distinct Features of Follicular Cytotoxic CD8bioRxiv : the preprint server for biology · 2026
    Article
  5. Regulators of CD8Nature reviews. Immunology · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. A pain from the nose to the head: neurological commitment during long COVID.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  11. Exploring current hypervirulentFrontiers in microbiology · 2025
    Review
  12. Article
  13. Review
  14. Roles of naïve CD4Journal of translational medicine · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Yuhong ChenBlood Research Institute, Versiti, Milwaukee, WI, USA.
Mei YuBlood Research Institute, Versiti, Milwaukee, WI, USA.
Yongwei ZhengBlood Research Institute, Versiti, Milwaukee, WI, USA.
Guoping FuBlood Research Institute, Versiti, Milwaukee, WI, USA.
Gang XinBlood Research Institute, Versiti, Milwaukee, WI, USA.
Wen ZhuBlood Research Institute, Versiti, Milwaukee, WI, USA.ORCID http://orcid.org/0000-0002-7734-9943
Lan LuoBlood Research Institute, Versiti, Milwaukee, WI, USA.
Robert BurnsBlood Research Institute, Versiti, Milwaukee, WI, USA.
Quan-Zhen LiDepartment of Immunology and Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Alexander L DentDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, USA.
Nan ZhuBlood Research Institute, Versiti, Milwaukee, WI, USA.
Weiguo CuiBlood Research Institute, Versiti, Milwaukee, WI, USA.ORCID http://orcid.org/0000-0003-1562-9218
Laurent MalherbeToxicology Division, Eli Lilly, Indianapolis, IN, USA.
Renren WenBlood Research Institute, Versiti, Milwaukee, WI, USA.
Demin WangBlood Research Institute, Versiti, Milwaukee, WI, USA. dwang@versiti.org.ORCID http://orcid.org/0000-0001-5549-3795
Versiti Blood Center of Wisconsin · USChinese PLA General Hospital · CNEli Lilly (United States) · USFujian Normal University · CNIndiana University School of MedicineMedical College of Wisconsin · USThe University of Texas Southwestern Medical Center · US

Funding

B cell responses in heparin-induced thrombocytopeniaR01HL130724 · NHLBI · VERSITI WISCONSIN, INC. · PI WANG, DEMIN · 2017 to 2024
$4.8M
PLC?s in B cell biology and autoimmunityR01AI079087 · NIAID · VERSITI WISCONSIN, INC. · PI WANG, DEMIN · 2008 to 2018
$4.4M
Molecular Basis of the Humoral Immune Response in Heparin-Induced ThrombocytopeniaR01HL148120 · NHLBI · VERSITI WISCONSIN, INC. · PI Renren Wen · 2019 to 2026
$3.8M
The control of allergic immune responses by follicular regulatory T cellsR01AI132771 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI DENT, ALEXANDER L · 2017 to 2021
$2.7M
The Cellular and Transcriptional Control of CD8 T Cell Functional Adaptation to Chronic VirusesR01AI125741 · NIAID · VERSITI WISCONSIN, INC. · PI CUI, WEIGUO · 2016 to 2020
$2.1M
NHLBI NIH HHS R01 HL130724NHLBI NIH HHS R01 HL148120NIAID NIH HHS R01 AI079087NIAID NIH HHS R01 AI125741NIAID NIH HHS R01 AI132771
6 · The paper itself

Abstract

Many autoimmune diseases are characterized by the production of autoantibodies. The current view is that CD4

Indexed as

AutoantibodiesAutoimmune DiseasesB-LymphocytesCD40 AntigensCD40 LigandCD8-Positive T-LymphocytesGene Expression ProfilingHumansImmune ToleranceProgrammed Cell Death 1 ReceptorReceptors, CXCR5STAT5 Transcription FactorT-Lymphocytes, Helper-InducerT-Lymphocyte SubsetsAutoantibodiesCD40 AntigensCD40 LigandCXCR5 protein, humanProgrammed Cell Death 1 ReceptorReceptors, CXCR5STAT5 Transcription Factor

Identifiers

PMID31562329
PMCPMC6765049
OpenAlexW2975765391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.